Eris Lifesciences acquires 51% stake in Swiss Parenterals for ₹637.50 crore

Source: Livemint New Delhi: Eris Lifesciences Ltd on Tuesday said it has acquired a 51% stake in the Swiss Parenterals Ltd (SPL) for ₹637.50 crore, aiming to expand its presence in the sterile injectables market. According to a stock exchange filing, this move will increase the total equity stake of Eris and its promoter group in […]